If the deals went to shareholders today, we believe Boston Scientific would prevail.
We expect prices to continue to decline. Leverage helps on the way up and it hurts on the day down. Boston Scientific recognizes it and that's why they want Guidant.
I don't see material upside or downside (for Boston Scientific shares) for the next 12 months.